EUVIMEDEUVIMED entdecken
Open Access · CC0

High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia

Ayalew Jejaw Zeleke iD, Abebe A Fola, George A Tollefson, Karamako Niaré, Alec Leonetti, Om Taropawala, Jacob Marglous, Rebecca Crudale, Bokretsion G Brhane, Ashenafi Assefa, Patience Kiyuka, Jonathan B Parr und 3 weitere

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1013771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Ayalew Jejaw Zeleke und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Parasitology, School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia. Hauptthemen laut MEDLINE: Plasmodium falciparum, Malaria, Falciparum, Protozoan Proteins, Antigens, Protozoan. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC0). Gefördert von: NIAID NIH HHS, European Union, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise of antimalarial drug-resistant Plasmodium falciparum threatens malaria elimination efforts. Mutations in the gene kelch13 ( k13 ) confer artemisinin partial resistance (ART-R), compromising the efficacy of frontline artemisinin-based combination therapies (ACTs). The validated mutation k13 R622I has emerged and expanded rapidly in the Horn of Africa. We conducted a year-long genomic surveillance study in Gondar Zuria and Tach Armachiho, two ecologically distinct districts in northwestern Ethiopia where R622I was first identified. A total of 903 P. falciparum infections were sequenced using molecular inversion probe (MIP) panels targeting major drug resistance mutations and genome-wide informative SNPs. The R622I mutation was found in 44.3% of samples, more frequent in Gondar Zuria than Tach Armachiho (52% vs. 35%; p < 0.001 ), and persisted year-round in nearly all sites, indicating stable transmission with minimal seasonal variation. Histidine-rich protein 2 (HRP2) based rapid diagnostic test (RDT) negativity was also prevalent (39.3%), with significant district-level variation (48.7% vs. 27.6%; p < 0.001 ). Concerningly, R622I and HRP2-RDT co-occured in 22% of samples, higher in Gondar Zuria than in Tach Armachiho (28.9% vs. 12.9%; p < 0.00 1). Overall, HRP2-RDT negativity was significantly more common among R622I mutant parasites than wild-type (48.3% vs. 30.7%; p < 0.05). The k13 C580Y mutation was also detected at very low frequency (0.4%) in Gondar Zuria, representing the first report of this mutation in the Horn of Africa. Long-read whole-genome sequencing showed k13 flanking haplotypes of C580Y isolates were distinct from Southeast Asian lineages, suggesting a local, de novo emergence of African origin. These findings highlight the increasing prevalence and types of ART-R mutations, persistence of k13 R622I and its increasing association with HRP2-RDT negativity, representing a double threat to malaria control and elimination efforts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plasmodium falciparumMalaria, FalciparumProtozoan ProteinsAntigens, ProtozoanDrug ResistanceEthiopiaHumansPrevalenceAntimalarialsMaleFemaleChild, PreschoolChildAdolescentMutationAdultYoung AdultDiagnostic Tests, RoutineInfantArtemisininsPolymorphism, Single Nucleotide

Substanzen

Protozoan ProteinsAntigens, ProtozoanAntimalarialsHRP-2 antigen, Plasmodium falciparumArtemisinins

Autor:innen und Institutionen

  • Department of Medical Parasitology, School of Biomedical and Laboratory Sciences, University of Gondar, Gondar, Ethiopia.
  • Department of Pathology and Laboratory Medicine, Brown University, Providence, Rhode Island, United States of America.
  • Center for Computational Molecular Biology, Brown University, Providence, Rhode Island, United States of America.
  • School of Public Health, Brown University, Providence, Rhode Island, United States of America.
  • Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Department of Microbial, Cellular and Molecular Biology, Addis Ababa University, Addis Ababa, Ethiopia.

ORCID-Profile: Ayalew Jejaw Zeleke, Jeffrey A Bailey

Förderung

  • NIAID NIH HHS
  • European Union
  • NIH

Zitieren

APA

Zeleke, A. J., Fola, A. A., Tollefson, G. A., Niaré, K., Leonetti, A., Taropawala, O., Marglous, J., Crudale, R., Brhane, B. G., Assefa, A., Kiyuka, P., Parr, J. B., Hailu, A., Tegegne, M. A., & Bailey, J. A. (2025). High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1013771

Vancouver

Zeleke AJ, Fola AA, Tollefson GA, Niaré K, Leonetti A, Taropawala O, et al. High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1013771

BibTeX
@article{Zeleke2025,
  author = {Zeleke, Ayalew Jejaw and Fola, Abebe A and Tollefson, George A and Niaré, Karamako and Leonetti, Alec and Taropawala, Om and Marglous, Jacob and Crudale, Rebecca and Brhane, Bokretsion G and Assefa, Ashenafi and Kiyuka, Patience and Parr, Jonathan B and Hailu, Asrat and Tegegne, Mulugeta Aemero and Bailey, Jeffrey A},
  title = {High prevalence and emerging positive association of kelch13 R622I and HRP2-based RDT negativity in Plasmodium falciparum in northern Ethiopia},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1013771}
}
Kostenlos starten →